Press "Enter" to skip to content

Patent delisted for Dermira Inc drug QBREXZA

0
Copyright © DrugPatentWatch. Originally published at Patent delisted for Dermira Inc drug QBREXZA

Annual Drug Patent Expirations for QBREXZA
Qbrexza is a drug marketed by Dermira Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

This drug has twenty-two patent family members in twelve countries.

The generic ingredient in QBREXZA is glycopyrronium tosylate. One supplier is listed for this compound. Additional details are available on the glycopyrronium tosylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at Patent delisted for Dermira Inc drug QBREXZA
    Do NOT follow this link or you will be banned from the site!